Gene · 3482
Papers4,462
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 4,462
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluating CNC Milling Performance for Machining AISI 316 Stainless Steel with Carbide Cutting Tool Insert. | Materials (Basel) | 2022 | 36431537 | PubTator, text mining | PubMed |
| Retrospective Analysis of Prognostic Factors in Pediatric Patients with Adrenocortical Tumor from Unique Tertiary Center with Long-Term Follow-Up. | J Clin Med | 2022 | 36431124 | PubTator, text mining | PubMed |
| Scalable Generation of Nanovesicles from Human-Induced Pluripotent Stem Cells for Cardiac Repair. | Int J Mol Sci | 2022 | 36430812 | PubTator, text mining | PubMed |
| Circulating Long Non-Coding RNAs Could Be the Potential Prognostic Biomarker for Liquid Biopsy for the Clinical Management of Oral Squamous Cell Carcinoma. | Cancers (Basel) | 2022 | 36428681 | PubTator, text mining | PubMed |
| Rose Virome Analysis and Identification of a Novel Ilarvirus in Taiwan. | Viruses | 2022 | 36423147 | PubTator, text mining | PubMed |
| Malignant fibroma presenting as a hypoglycemia and coma in a 45-year-old male patient: A case report. | Clin Case Rep | 2022 | 36419579 | PubTator, text mining | PubMed |
| Brain transplantation of genetically corrected Sanfilippo type B neural stem cells induces partial cross-correction of the disease. | Mol Ther Methods Clin Dev | 2022 | 36419468 | PubTator, text mining | PubMed |
| Screening chimeric GAA variants in preclinical study results in hematopoietic stem cell gene therapy candidate vectors for Pompe disease. | Mol Ther Methods Clin Dev | 2022 | 36419467 | PubTator, text mining | PubMed |
| Evolution of complexity in non-viral oligonucleotide delivery systems: from gymnotic delivery through bioconjugates to biomimetic nanoparticles. | RNA Biol | 2022 | 36411594 | PubTator, text mining | PubMed |
| Retinoic acid-induced 1 gene haploinsufficiency alters lipid metabolism and causes autophagy defects in Smith-Magenis syndrome. | Cell Death Dis | 2022 | 36411275 | PubTator, text mining | PubMed |
| A panel of seven immune-related genes can serve as a good predictive biomarker for cervical squamous cell carcinoma. | Front Genet | 2022 | 36406134 | PubTator, text mining | PubMed |
| Leishmania kinetoplast DNA contributes to parasite burden in infected macrophages: Critical role of the cGAS-STING-TBK1 signaling pathway in macrophage parasitemia. | Front Immunol | 2022 | 36405710 | PubTator, text mining | PubMed |
| Glycoproteomics revealed novel N-glycosylation biomarkers for early diagnosis of lung adenocarcinoma cancers. | Clin Proteomics | 2022 | 36401165 | PubTator, text mining | PubMed |
| Impairment in quantitative microvascular function in non-ischemic cardiomyopathy as demonstrated using cardiovascular magnetic resonance. | PLoS One | 2022 | 36399465 | PubTator, text mining | PubMed |
| Age-related changes in Folliculogenesis and potential modifiers to improve fertility outcomes - A narrative review. | Reprod Biol Endocrinol | 2022 | 36397149 | PubTator, text mining | PubMed |
| Transplantable human thyroid organoids generated from embryonic stem cells to rescue hypothyroidism. | Nat Commun | 2022 | 36396935 | PubTator, text mining | PubMed |
| Identification of risk model based on glycolysis-related genes in the metastasis of osteosarcoma. | Front Endocrinol (Lausanne) | 2022 | 36387908 | PubTator, text mining | PubMed |
| Endocrine disruptor chemicals as obesogen and diabetogen: Clinical and mechanistic evidence. | World J Clin Cases | 2022 | 36387809 | PubTator, text mining | PubMed |
| A Look Into the Next Century After 100 Years of Insulin. | Cureus | 2022 | 36381916 | PubTator, text mining | PubMed |
Down-regulation of hepatic expression of GHR/STAT5/IGF-1 signaling pathway fosters development and aggressiveness of HCV-related hepatocellular carcinoma: Crosstalk with Snail-1 and type 2 transforming growth factor-beta receptor. | PLoS One | 2022 | 36374927 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3482/papers?page=29